What do systematic reviews say?

Endovenous laser ablation (EVLA) vs radiofrequency ablation

Endovenous laser ablation (EVLA) showed no clear difference in technical success (< 5 years) compared with radiofrequency ablation (RFA) (moderate certainty).

• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  OR 0.98 [0.41, 2.38]
  5 studies · 780 participants
  Moderate
• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  OR 0.85 [0.3, 2.41]
  1 study · 291 participants
  Low

Endovenous laser ablation (EVLA) vs radiofrequency ablation

Endovenous laser ablation (EVLA) showed no clear difference in recurrence (< 5 years) compared with radiofrequency ablation (RFA) (low certainty).

• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  OR 1.53 [0.78, 2.99]
  1 study · 291 participants
  Low

Endovenous laser ablation (EVLA) vs radiofrequency ablation

Endovenous laser ablation (EVLA) may leads to higher long‐term recurrence (> 5 years) compared with radiofrequency ablation (RFA) (low certainty).

• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  OR 2.77 [1.52, 5.06]
  1 study · 291 participants
  Low

Endovenous laser ablation (EVLA) vs radiofrequency ablation

• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Very low

Endovenous laser ablation (EVLA) vs radiofrequency ablation

• Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate